QuidelOrtho
QDEL
$86.07
Share price
1.20%
Change (1 day)
-7.84%
Change (1 year)
Quidel is an American manufacturer of diagnostics testings that can be used to diagnose infectious diseases as well as cardiovascular and metabolic diseases.
QuidelOrtho (QDEL) - Total debt
Total debt on the balance sheet as of March 2023 : $2.77 B
According to QuidelOrtho's latest financial reports the company's total debt is $2.77 B. A company’s total debt is the sum of all current and non-current debts.
QuidelOrtho - Total debt on balance sheet (from 2001 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2022-12-31 | $2.84 B | 1955.7% |
| 2021-12-31 | $0.13 B | 27.73% |
| 2020-12-31 | $0.10 B | -3.38% |
| 2019-12-31 | $0.11 B | 4.4% |
| 2018-12-31 | $0.10 B | -72.94% |
| 2017-12-31 | $0.39 B | 167.79% |
| 2016-12-31 | $0.14 B | 0.34% |
| 2015-12-31 | $0.14 B | 0.47% |
| 2014-12-31 | $0.14 B | 2544.57% |
| 2013-12-31 | $5.56 M | -49.15% |
| 2012-12-31 | $10.94 M | -77.32% |
| 2011-12-31 | $48.27 M | -39.7% |
| 2010-12-31 | $80.05 M | 1084.06% |
| 2009-12-31 | $6.76 M | -3.4% |
| 2008-12-31 | $6.99 M | -9.85% |
| 2007-12-31 | $7.76 M | -8% |
| 2006-12-31 | $8.43 M | -42.63% |
| 2005-12-31 | $14.71 M | 52.01% |
| 2004-12-31 | $9.67 M | -5.09% |
| 2003-12-31 | $10.19 M | -4.26% |
| 2002-12-31 | $10.65 M | -22.42% |
| 2001-12-31 | $13.72 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Thermo Fisher Scientific TMO | $35.25 B | 1,172.63% | 🇺🇸 USA |
 Becton Dickinson BDX | $18.22 B | 557.81% | 🇺🇸 USA |
 Danaher DHR | $19.83 B | 615.85% | 🇺🇸 USA |
 PerkinElmer
PKI | $4.59 B | 65.88% | 🇺🇸 USA |
 OraSure Technologies OSUR | $12.54 M | -99.55% | 🇺🇸 USA |
 Meridian Bioscience VIVO | $30.95 M | -98.88% | 🇺🇸 USA |